NCT05541497View on ClinicalTrials.gov

Varenicline for Treatment of E-cigarette Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 4, 2022

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Smoking Cessation
Interventions
DRUG

Varenicline Tartrate

Days 1-3: 0.5mg study pill once per day, Days 4-7: 0.5mg study pill twice per day, Weeks 2-8: 1mg study pill twice per day

DRUG

Placebo

Days 1-3: 0.5mg pill once per day, Days 4-7: 0.5mg pill twice per day, Weeks 2-8: 1mg pill twice per day

Trial Locations (2)

29425

Medical University of South Carolina, Charleston

06520

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER